Rusli Ismail

2.3k total citations
124 papers, 1.8k citations indexed

About

Rusli Ismail is a scholar working on Pharmacology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Rusli Ismail has authored 124 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pharmacology, 35 papers in Pharmacology and 29 papers in Organic Chemistry. Recurrent topics in Rusli Ismail's work include Pharmacogenetics and Drug Metabolism (34 papers), Synthesis and biological activity (19 papers) and Eicosanoids and Hypertension Pharmacology (16 papers). Rusli Ismail is often cited by papers focused on Pharmacogenetics and Drug Metabolism (34 papers), Synthesis and biological activity (19 papers) and Eicosanoids and Hypertension Pharmacology (16 papers). Rusli Ismail collaborates with scholars based in Malaysia, India and Iraq. Rusli Ismail's co-authors include Siew Hua Gan, Lay Kek Teh, Tan Soo Choon, Chin Eng Ong, Raju Suresh Kumar, Ang Chee Wei, Keng Yoon Yeong, Hasnah Osman, Joon Wah Mak and Yan Pan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Tetrahedron.

In The Last Decade

Rusli Ismail

122 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rusli Ismail Malaysia 24 559 467 298 291 187 124 1.8k
Oliver Yoa‐Pu Hu Taiwan 24 355 0.6× 113 0.2× 305 1.0× 176 0.6× 195 1.0× 86 1.7k
W. Meuldermans Belgium 30 871 1.6× 121 0.3× 590 2.0× 432 1.5× 494 2.6× 70 2.8k
Soo Choon Tan Malaysia 18 172 0.3× 198 0.4× 256 0.9× 223 0.8× 99 0.5× 61 1.3k
Peter J. Hayball Australia 24 278 0.5× 746 1.6× 305 1.0× 222 0.8× 125 0.7× 40 2.1k
Jih‐Heng Li Taiwan 28 308 0.6× 145 0.3× 526 1.8× 343 1.2× 71 0.4× 67 2.2k
J Kvĕtina Czechia 20 264 0.5× 79 0.2× 267 0.9× 272 0.9× 229 1.2× 112 1.3k
Milan Nobilis Czechia 18 223 0.4× 106 0.2× 275 0.9× 235 0.8× 168 0.9× 62 1.1k
Abdul Mutlib United States 24 825 1.5× 405 0.9× 902 3.0× 388 1.3× 339 1.8× 61 2.5k
Fakhreddin Jamali Canada 20 318 0.6× 87 0.2× 240 0.8× 574 2.0× 188 1.0× 39 1.4k
Robert A. Upton United States 27 425 0.8× 66 0.1× 339 1.1× 675 2.3× 220 1.2× 62 2.2k

Countries citing papers authored by Rusli Ismail

Since Specialization
Citations

This map shows the geographic impact of Rusli Ismail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rusli Ismail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rusli Ismail more than expected).

Fields of papers citing papers by Rusli Ismail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rusli Ismail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rusli Ismail. The network helps show where Rusli Ismail may publish in the future.

Co-authorship network of co-authors of Rusli Ismail

This figure shows the co-authorship network connecting the top 25 collaborators of Rusli Ismail. A scholar is included among the top collaborators of Rusli Ismail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rusli Ismail. Rusli Ismail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Othman, Zahiruddin, et al.. (2020). Tualang honey supplementation as cognitive enhancer in patients with schizophrenia. Heliyon. 6(5). e03948–e03948. 12 indexed citations
2.
Yasin, Mohd Azhar Mohd, et al.. (2017). ABCB1 Polymorphisms and Cold Pressor Pain Responses. Nursing Research. 66(2). 134–144. 10 indexed citations
3.
Lee, Yeong Yeh, et al.. (2016). 118A>G AND IVS2+691G>C POLYMORPHISMS OF OPRM1 GENE HAVE NO INFLUENCE ON COLD-PAIN SENSITIVITY AMONG HEALTHY OPIOID-NAIVE MALAY MALES. International Journal of Pharmacy and Pharmaceutical Sciences. 8(7). 73–80. 4 indexed citations
4.
Yasin, Mohd Azhar Mohd, et al.. (2016). Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT). Drug and Alcohol Dependence. 165. 143–150. 9 indexed citations
5.
6.
El‐Bassel, Nabila, Philippe Adam, Louisa Gilbert, et al.. (2015). Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen. PLoS ONE. 10(8). e0118422–e0118422. 14 indexed citations
7.
Yeong, Keng Yoon, Mohamed Ashraf Ali, Tan Soo Choon, et al.. (2013). Antituberculosis: Synthesis and Antimycobacterial Activity of Novel Benzimidazole Derivatives. BioMed Research International. 2013. 1–6. 29 indexed citations
8.
Ismail, Rusli, et al.. (2012). Chemical composition and antioxidant activity of the crude methanolic extracts of Mentha spicata. SHILAP Revista de lepidopterología. 4(1). 13–18. 23 indexed citations
9.
Ali, Mohamed Ashraf, Sylvaine Bastian, Rusli Ismail, et al.. (2011). Discovery of novel methanone derivatives acting as antimycobacterial agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 26(6). 890–894. 1 indexed citations
10.
Ismail, Rusli, et al.. (2010). Golongan Muda Mat Rempit: Suatu Ekspresi Sub Budaya. 5(1). 10. 2 indexed citations
11.
Tiong, Kai Hung, et al.. (2010). Functional Characterization of Cytochrome P450 2A6 Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22. Drug Metabolism and Disposition. 38(5). 745–751. 9 indexed citations
12.
Tiong, Kai Hung, et al.. (2010). In vitromodulation of naturally occurring flavonoids on cytochrome P450 2A6 (CYP2A6) activity. Xenobiotica. 40(7). 458–466. 17 indexed citations
13.
Gan, Siew Hua, et al.. (2007). Impact of CYP2D6 Genetic Polymorphism on Tramadol Pharmacokinetics and Pharmacodynamics. Molecular Diagnosis & Therapy. 11(3). 171–181. 67 indexed citations
14.
Teh, Lay Kek, et al.. (2007). Single step PCR for detection of allelic variation of MDR1 gene (P-glycoprotein) among three ethnic groups in Malaysia. Journal of Clinical Pharmacy and Therapeutics. 32(3). 313–319. 19 indexed citations
15.
Teh, Lay Kek, et al.. (2004). A simple and rapid genotyping method for beta-2 receptor (beta2 AR) gene using allele specific multiplex PCR. Journal of Clinical Pharmacy and Therapeutics. 29(1). 47–52. 4 indexed citations
16.
Gan, Siew Hua, et al.. (2002). Method development and validation of a high-performance liquid chromatographic method for tramadol in human plasma using liquid–liquid extraction. Journal of Chromatography B. 772(1). 123–129. 76 indexed citations
17.
Gan, Siew Hua & Rusli Ismail. (2001). Validation of a high-performance liquid chromatography method for tramadol and o-desmethyltramadol in human plasma using solid-phase extraction. Journal of Chromatography B Biomedical Sciences and Applications. 759(2). 325–335. 74 indexed citations
18.
Teh, Lay Kek, et al.. (2001). Heterogeneity of the CYP2D6 gene among Malays in Malaysia. Journal of Clinical Pharmacy and Therapeutics. 26(3). 205–211. 46 indexed citations
19.
Ismail, Rusli, Ab Fatah Ab Rahman, & Prem Chand. (1994). Pharmacokinetics of phenytoin in routine clinic patients in Malaysia. Journal of Clinical Pharmacy and Therapeutics. 19(4). 245–248. 6 indexed citations
20.
Ismail, Rusli, et al.. (1993). Estimation of population pharmacokinetics for carbamazepine in Malaysian patients using the OPT® computer program. Journal of Clinical Pharmacy and Therapeutics. 18(1). 55–58. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Yoa‐Pu Hu Breakdown of academic impact, for papers by W. Meuldermans Breakdown of academic impact, for papers by Soo Choon Tan Breakdown of academic impact, for papers by Peter J. Hayball Breakdown of academic impact, for papers by Jih‐Heng Li Breakdown of academic impact, for papers by J Kvĕtina Breakdown of academic impact, for papers by Milan Nobilis Breakdown of academic impact, for papers by Abdul Mutlib Breakdown of academic impact, for papers by Fakhreddin Jamali Breakdown of academic impact, for papers by Robert A. Upton
Rankless by CCL
2026